Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomas(†)

The objective of this study was to evaluate whether longitudinal levels of serum YKL-40 correlate with disease status or survival in adults with gliomas. Patients with histologically confirmed gliomas were eligible for this longitudinal study. Serum samples were collected prospectively and concurren...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Iwamoto, Fabio M., Hottinger, Andreas F., Karimi, Sasan, Riedel, Elyn, Dantis, Jocelynn, Jahdi, Maryam, Panageas, Katherine S., Lassman, Andrew B., Abrey, Lauren E., Fleisher, Martin, DeAngelis, Lisa M., Holland, Eric C., Hormigo, Adília
פורמט: Artigo
שפה:Inglês
יצא לאור: Oxford University Press 2011
נושאים:
Clinical Investigations
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3199155/
https://ncbi.nlm.nih.gov/pubmed/21831900
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nor117
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים